Cargando…
Convalescent plasma to treat COVID-19: clinical experience and efficacy
The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indicati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034927/ https://www.ncbi.nlm.nih.gov/pubmed/33735836 http://dx.doi.org/10.18632/aging.202795 |
_version_ | 1783676621521158144 |
---|---|
author | Pei, Shiyao Yuan, Xi Zhang, Zhimin Yao, Run Xie, Yubin Shen, Minxue Li, Bijuan Chen, Xiang Yin, Mingzhu |
author_facet | Pei, Shiyao Yuan, Xi Zhang, Zhimin Yao, Run Xie, Yubin Shen, Minxue Li, Bijuan Chen, Xiang Yin, Mingzhu |
author_sort | Pei, Shiyao |
collection | PubMed |
description | The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indications, contraindications of the convalescent plasmas and reported the effectiveness of convalescent plasma therapy by a retrospective cohort study. |
format | Online Article Text |
id | pubmed-8034927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-80349272021-04-16 Convalescent plasma to treat COVID-19: clinical experience and efficacy Pei, Shiyao Yuan, Xi Zhang, Zhimin Yao, Run Xie, Yubin Shen, Minxue Li, Bijuan Chen, Xiang Yin, Mingzhu Aging (Albany NY) Research Paper The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indications, contraindications of the convalescent plasmas and reported the effectiveness of convalescent plasma therapy by a retrospective cohort study. Impact Journals 2021-03-18 /pmc/articles/PMC8034927/ /pubmed/33735836 http://dx.doi.org/10.18632/aging.202795 Text en Copyright: © 2021 Pei et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Pei, Shiyao Yuan, Xi Zhang, Zhimin Yao, Run Xie, Yubin Shen, Minxue Li, Bijuan Chen, Xiang Yin, Mingzhu Convalescent plasma to treat COVID-19: clinical experience and efficacy |
title | Convalescent plasma to treat COVID-19: clinical experience and efficacy |
title_full | Convalescent plasma to treat COVID-19: clinical experience and efficacy |
title_fullStr | Convalescent plasma to treat COVID-19: clinical experience and efficacy |
title_full_unstemmed | Convalescent plasma to treat COVID-19: clinical experience and efficacy |
title_short | Convalescent plasma to treat COVID-19: clinical experience and efficacy |
title_sort | convalescent plasma to treat covid-19: clinical experience and efficacy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034927/ https://www.ncbi.nlm.nih.gov/pubmed/33735836 http://dx.doi.org/10.18632/aging.202795 |
work_keys_str_mv | AT peishiyao convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT yuanxi convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT zhangzhimin convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT yaorun convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT xieyubin convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT shenminxue convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT libijuan convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT chenxiang convalescentplasmatotreatcovid19clinicalexperienceandefficacy AT yinmingzhu convalescentplasmatotreatcovid19clinicalexperienceandefficacy |